company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11842000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,12000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11854000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,669000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12364000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8852000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7673000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-1000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7674000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1932000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,384000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10639000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-810000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8276000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8276000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-39000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,561000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,39000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q3,2010-07-01,2010-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4503000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,2155000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2348000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,95000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-58000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3663000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1278000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-22000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1300000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,128000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1791000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2734000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-43000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1028000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1028000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-91000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-87000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-178000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-178000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-450000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,19000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9625000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,4000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9621000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,564000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-58000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9216000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,911000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,911000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-32024000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13888000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-28000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23169000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23169000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,55000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24945000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24945000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2687000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,321000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q1,2011-01-01,2011-03-31,2012-11-14 14:01:44+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,27000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-422000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-422000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,785000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,877000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9285000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8045000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8045000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5458000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,453000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,453000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-110000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5110000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2592000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,772000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4174000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-1000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4173000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,750000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4215000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1847000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1055000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1055000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-111000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-26000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-137000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-137000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1190000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,656000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4686000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4686000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,691000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,283000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1357000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7017000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7017000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,38000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,530000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2847000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2279000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2279000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4790000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,714000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1133000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,1871000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-738000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,678000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,169000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-278000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-169000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-200000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-369000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,13000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4549000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3945000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3945000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,160000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-840000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-840000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2736000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,631000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:09:09+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2529000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,1799000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4328000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,662000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2826000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,108000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-732000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-732000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-242000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-242000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-242000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,70000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,82000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,82000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-892000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,671000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-194000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-194000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,638000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1084000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-560000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-350000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-910000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-372000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2368000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2368000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1500000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2645000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,294000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1439000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1439000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1839000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,552000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1063000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-1523000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2586000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,749000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2577000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3390000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2522000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-350000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2172000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,38000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-113000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-72000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-72000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2598000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,637000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3235000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3235000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5335000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,598000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-15000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6091000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,2397000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3694000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,669000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-769000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3343000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6937000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6937000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,37000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3729000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3692000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3692000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3219000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,860000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2359000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2359000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,886000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,254000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1965000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1965000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,668000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2065000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5057000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-359000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-359000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,18000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-245000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-245000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3291000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1243000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2048000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2048000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2652000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,321000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2097000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2097000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,668000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3643000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3831000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2577000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2577000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,626000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1618000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-998000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-998000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3436000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3195000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-241000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-241000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1338000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,110000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 08:38:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1287000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1287000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,669000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2516000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-464000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4008000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4008000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,6000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,125000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,529000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-51000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,609000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,609000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3511000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,453000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3058000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3058000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1559000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,102000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,776000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,776000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,661000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1223000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5048000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3973000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3735000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3735000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-1000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-267000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,73000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,73000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8128000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-38523000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,245000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11637000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-47667000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,162319000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,162319000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,166127000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,282000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6732000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6732000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,659000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2471000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2449000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2065000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10246000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10246000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-124000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,846000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2427000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1711000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1711000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-29431000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,437000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-28995000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-28995000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20460000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,650000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2509000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3363000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1146000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7579000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7579000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,459000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3247000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2797000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2797000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,781000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,781000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,781000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5563000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,903000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q1,2015-01-01,2015-03-31,2016-11-14 18:10:40+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,22027000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22027000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,646000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2515000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-17233000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2091000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10046000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10046000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9247000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60432000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1919000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4446000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-72223000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-72223000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4649000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4649000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4649000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-57528000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,199165000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,199165000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,644000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2695000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1219000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-193286000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10437000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10437000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,9000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60356000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26269000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1278000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26365000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26365000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-489000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1949000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1460000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1460000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14468000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,919000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6341000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,687000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2555000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5237000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1155000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13665000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13665000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-66000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45237000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-1000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44626000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10799000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11477000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11477000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1470000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1470000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1470000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3658000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6608000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,731000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5877000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2575000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2988000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6638000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4964000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13114000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13114000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-238000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-92855000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49892000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68671000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5446000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-79760000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-79760000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-502000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1013000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,511000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,511000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-66135000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,919000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:23:04+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6170000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6170000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2813000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2721000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15597000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4590000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10371000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10371000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-783000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-349000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37229000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-17880000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18217000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18217000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1469000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1469000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1469000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30057000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,35000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5079000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5079000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2979000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2838000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2194000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6134000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19224000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19224000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-73352000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47771000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-87000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25668000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25668000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1667000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1667000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1667000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8111000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,919000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:08:22+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,96000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6058000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6058000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2585000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2882000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6850000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7989000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10386000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10386000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50930000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,87384000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2747000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39201000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39201000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49582000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,36000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8429000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8429000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2017000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2927000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12099000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2178000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27650000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27650000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-80839000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24122000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,179000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-56538000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-56538000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1404000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1404000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1404000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27484000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,919000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,13000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7010000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7010000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3374000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2891000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5166000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26889000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,31310000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,31310000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2156000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-26653000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49137000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37557000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4215000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36174000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36174000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1966000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5289000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7255000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7255000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12119000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,45279000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45279000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3002000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3018000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16291000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6829000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,60761000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,60761000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98957000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,66616000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1240000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33581000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1895000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5119000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3224000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3224000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30404000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,919000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:04:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,171000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,73162000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73162000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3011000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11287000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-33295000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,19479000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,73644000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,73644000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-646826000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56350000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3738000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-586738000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-586738000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-38685000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-50832000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,750000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,90000000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-136954000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,613529000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,613529000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,100435000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,114000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,67362000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,67362000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5408000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7070000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-53494000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,736000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27082000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27082000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-412507000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,334717000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-462000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-78252000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-78252000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,52129000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6788000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58917000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58917000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7747000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,594000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,56000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42482000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42482000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1363000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,17127000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,79164000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22600000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,32572000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,32572000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-887000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5856000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-275965000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,571046000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-13036000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,275302000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,275302000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-195889000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100235000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-52129000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1168000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-347085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-347085000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39211000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,666337000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,666337000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3841000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8065000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-823340000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,190355000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45258000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45258000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1047767000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,812797000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,332988000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3241000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,94777000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,94777000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-151585000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-991000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-152576000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-152576000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,130000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12411000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,102000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:28:04+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,60000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14419000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14419000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4940000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5281000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6517000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-63377000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-61058000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-61058000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-233507000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,501742000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2432000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,265803000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,265803000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-38332000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,741000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-37591000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-37591000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-123000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,167031000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2813000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,69643000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15251000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15251000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3779000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10874000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16595000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22194000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6197000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6197000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,169517000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-27323000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-181189000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12401000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15201000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-211312000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-211312000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48087000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,100000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,24114000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7365000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7365000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5801000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-4506000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22357000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-23626000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7339000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7339000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2553000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-673959000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,611695000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1638000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-63179000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-63179000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-82322000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-12401000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11030000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-83693000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-83693000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-154123000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2812000.0
Ligand Pharmaceuticals Inc,LGND,5493008K7TB0IKP37H79,0000886163,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10000000.0
